IP Verse

Amarin Pharmaceuticals Ireland Limited opposition analysis

COMPANY ANALYSIS

Latest patents of Amarin Pharmaceuticals Ireland Limited opposed by its competitors

Patent:
EP2800469
Grant Date:
Aug 25, 2021
Title:
Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A Subject
Oppositions:
2
Patent:
EP3318255
Grant Date:
Mar 10, 2021
Title:
Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy
Oppositions:
3
Patent:
EP3363433
Grant Date:
Dec 9, 2020
Title:
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy
Oppositions:
3
Patent:
EP3278665
Grant Date:
Sep 9, 2020
Title:
Stable Pharmaceutical Composition And Methods Of Using Same
Oppositions:
1
Patent:
EP2596786
Grant Date:
Nov 27, 2019
Title:
Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
Oppositions:
2
Patent:
EP3037089
Grant Date:
Nov 27, 2019
Title:
Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
Oppositions:
2

Competitors of Amarin Pharmaceuticals Ireland Limited

ELKINGTON AND FIFE LLP

COOKE, RICHARD

HOFFMANN EITLE

Want to track Amarin Pharmaceuticals Ireland Limited?

Feel free to send us a message here and we will get back to you